Insights
Gain perspectives from experts on various policy issues and therapeutic areas through our Insights series that engages multiple managed care stakeholders in video interviews.
October 14, 2019 –
Omid Hamid, MD, and Morgana Freeman, MD, discuss primary treatment options for locally advanced or metastatic CSCC and when it’s appropriate to elect for surgery.
October 14, 2019 –
An overview of cutaneous squamous cell carcinoma (CSCC), including diagnosis, distinguishing CSCC from head and neck cancer, and risk factors for developing advanced disease.
August 28, 2019 –
Concluding their insights on the management of interstitial lung disease (ILD), experts look forward to the future treatment paradigm.
August 28, 2019 –
A comprehensive breakdown of treatment strategies for interstitial lung disease in systemic sclerosis.
August 21, 2019 –
Experts reflect on the prevalence and implications of interstitial lung disease in systemic sclerosis.
August 21, 2019 –
Specific considerations are given for the identification and management of progressive fibrosing–interstitial lung disease.
August 14, 2019 –
Regarding interstitial lung disease, Alicia M. Hinze, MD, elucidates immunosuppressive approaches and beneficial lifestyle changes.
August 14, 2019 –
Shifting their focus to pharmacological management of interstitial lung disease (ILD), experts review approved treatment options.
August 08, 2019 –
Highlights from clinical guidelines and therapeutic goals related to the management of interstitial lung disease (ILD).
August 08, 2019 –
An outline of the many factors that play into the direct and indirect costs of interstitial lung disease (ILD).
